Sign inJoin waitlistJoin the waitlist

KH

Kim Hirshfield

, Medical Oncologist · Rutgers Health

Credentials: · · ·

History

Rutgers Health
Present

Medical Oncology
Internal Medicine

Research

Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer
Case report · Journal of Clinical Investigation · 2016 · 322 citations
MDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent manner
Cancer Research · 2006 · 251 citations
Contribution of serine, folate and glycine metabolism to the ATP, NADPH and purine requirements of cancer cells
Cell Death and Disease · 2013 · 222 citations

Shridar Ganesan
24 papers
SA
Siraj Ali
11 papers
Deborah Toppmeyer
8 papers
Gregory Riedlinger
8 papers
Robert DiPaola
7 papers
Jeffrey Ross
6 papers
Mark Stein
6 papers
Bruce Haffty
4 papers
HZ
Hua Zhong
4 papers
Janice Mehnert
4 papers
JB
Joseph Bertino
4 papers
JE
Julia Elvin
4 papers

Clinical trials

Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients With Triple Negative Stage II-III Breast Cancer
Principal investigator · Active not recruiting · Phase 2
Rutgers, The State University of New Jersey
2015–2041
Collecting and Storing Blood Samples From Patients With Cancer
Principal investigator · Withdrawn
University of Medicine and Dentistry of New Jersey
2004–2011
DNA Changes in Patients With Prostate Cancer
Study chair · Completed
ECOG-ACRIN Cancer Research Group
2006–2007